K. Longenecker

Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer

L. Lam, Chaohong Sun, S. Rosenberg, 2020, Nature.

An anti-PD-1–GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy

W. Liu, Z. Dezső, L. Bigelow, 2022, Nature Cancer.

Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors.

H. Sham, Xiaofen Li, D. Beno, 2006, Journal of Medicinal Chemistry.

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity

Yi Yang, M. Rees, K. Yates, 2023, Nature.

Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex

Chaohong Sun, C. Nasveschuk, Gesine K. Veits, 2024, Communications chemistry.